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The C-terminal region of peripherin/rds contains three predicted α-helical domains. One of these
domains, corresponding to amino acids 311–322, form an amphiphilic α-helix previously shown
to promote membrane fusion. The present studies were conducted to determine how the additional
α-helical regions of the peripherin/rds C-terminus affect complex formation with rom-1,
glycosylation, intracellular localization and membrane fusion properties. Bovine peripherin/rds
and rom-1 were epitope tagged with an amino-terminal FLAG-tag or amino-terminal
hemagglutinin (HA)-tag, respectively, and cloned into the pCI-neo expression vector for transient
transfection into COS cells. Similarly, four C-terminal peripherin/rds truncation mutants (Δ1, Δ2,
Δ3 and Δ4), corresponding to deletions of −19, −29, −39 and −59 amino acids were designed to
disrupt the α-helical domains. Immunofluorescence microscopy and enzymatic digestions
demonstrated that full-length peripherin/rds and the four C-terminal deletion mutants were
localized to intracellular membranes and were all Endo-H sensitive. Western blotting and
immunoprecipitation studies showed that the FLAG-tagged bovine peripherin/rds (full-length) was
expressed as a 76 kDa dimer, which associates with HA-tagged rom-1 to form a higher order
complex. The deletion mutants were also able to associate with rom-1. However, when analyzed
using non-denaturing tricine electrophoresis, full-length peripherin/rds and the Δ1, Δ2 and Δ3
mutants formed homo-oligomeric complexes, while the Δ4 mutant appeared to form only
homodimers suggesting a region upstream of amino acid 300 may be involved in C-terminal
interactions. Membrane fusion was then evaluated using fluorescence resonance energy transfer
(RET) techniques. Intracellular COS cell membranes containing full-length peripherin/rds fused
with rod outer segment plasma membrane vesicles. This fusion was inhibited with the addition of
a synthetic peptide (PP-5) corresponding to the fusion domain of peripherin/rds. In contrast, fusion
was negligible with any of the C-terminal truncation mutants. Collectively, these results suggest
that in addition to the fusion domain, other regions of the peripherin/rds C-terminus are required
for fusion. Most interesting is the observation that the last 19 amino acids, a region downstream of
the fusion peptide that is deleted in the Δ1 mutant, appear to be necessary for fusion. This region
corresponds to the epitope for anti-peripherin/ rds monoclonal antibody 2B6, which is shown to
partially inhibit peripherin/rds mediated membrane fusion.
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1. Introduction
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The retinal degeneration slow or rds mouse is a model for a group of inherited human
diseases known collectively as retinitis pigmentosa (van Nie et al., 1978). Mice homozygous
for the rds mutation do not develop photoreceptor outer segments and exhibit a slow
progressive loss of rods and cones (Sanyal and Jansen, 1981). The underlying defect is an
insertion of a 9·2 kbp repetitive sequence element into a gene known as peripherin/rds
(Travis et al., 1989). Subsequent studies have shown that mutations in the human
peripherin/rds gene also cause a variety of retinal dystrophies including autosomal dominant
retinitis pigmentosa and macular dystrophy (Kohl et al., 1998).
Peripherin/rds is a 346 amino acid integral membrane glycoprotein expressed exclusively in
the outer segments of rod and cone cells (Connell and Molday, 1990; Travis et al., 1991).
Within the photoreceptor disk rim, peripherin/rds is oriented such that both the N-terminus
and C-terminus are exposed to the cytoplasm (Arikawa et al., 1992). The protein has four
predicted transmembrane domains and consequently two intradiskal loops (D1 and D2). The
D1 loop is located between the first and second transmembrane domains while the D2 loop,
the larger of the two, is located between the third and fourth transmembrane domains.
Peripherin/rds is highly conserved with amino acid identities of greater than 90% between
species (Kedzierski et al., 1996). It has two potential N-linked glycosylation sites although
only asparagine 229 is glycosylated in vivo (Kedzierski et al., 1999).
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In rod outer segment (ROS) disk membranes, peripherin/rds forms disulfide-linked
homodimers, via cysteine residue 150 located within the D2 loop (Goldberg et al., 1998). A
significant portion of these homodimers form disulfide-linked homotetrameric and
octameric complexes (Loewen and Molday, 2000). Peripherin/rds homodimers also
associate with homodimers of the related disk rim protein, rom-1 to form multisubunit
complexes (Travis et al., 1991; Goldberg et al., 1995; Goldberg and Molday, 1996). Rom-1
is a 37 kDa, non-glycosylated structural homolog of peripherin/rds that is expressed in the
rim region of rod disk membranes (Bascom et al., 1992; Moritz and Molday, 1996).
Although the function(s) of peripherin/rds remains elusive, it is proposed to serve an
important role in the structural maintenance of rod and cone outer segments (Travis et al.,
1991; Bascom et al., 1992; Goldberg et al., 1995). This is directly supported by in vitro
studies showing that expression of peripherin/rds confers a flattened morphology upon
microsomal membranes (Wrigley et al., 2000). More recently, Poetsch et al. (2001) have
shown that peripherin/rds interacts with glutamic acid rich proteins (GARP) associated with
the β-subunit of the cGMP-gated channel located in ROS plasma membranes.
While the D-2 loop of peripherin/rds (the region containing the highest concentration of
disease-linked mutations) has been well characterized, very little is known about this
proteins’ C-terminal domain. One postulated function for the peripherin/rds C-terminus is
that of a membrane fusion protein. In ROS, membrane fusion events are necessary for both
Exp Eye Res. Author manuscript; available in PMC 2016 February 09.

Muller-Weeks et al.

Page 3

Author Manuscript

disk morphogenesis and shedding (Steinberg et al., 1980; Matsumoto and Besharse, 1995).
Purified, native peripherin/rds has been shown to promote fusion of recombinant disk lipid
vesicles with ROS plasma membrane vesicles (Boesze-Battaglia et al., 1998). The putative
fusion domain is an amphiphilic α-helical region located within the peripherin/rds Cterminus. Notably, a synthetic peptide (PP-5) corresponding to this 15 amino acid fusion
domain, can mediate individual steps of membrane fusion including aggregation and
membrane destabilization (Boesze-Bataglia et al., 1998, 2000).
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In addition to the fusion domain, there are two other predicted α-helical domains located
within the peripherin/rds C-terminus. This region may not only be involved in membrane
fusion processes, but is proposed to contain a ROS specific localization signal (based on
green fluorescent protein (GFP)-fusion constructs) (Tam et al., 2001). Its importance is also
illustrated clinically by several chain termination and frame-shift mutations that result in
proteins lacking various portions of the C-terminus. Individuals that have inherited these
mutations present with heterogeneous disease phenotypes including pattern dystrophy and
vitelliform macular dystrophy (Felbor et al., 1997; Kohl et al., 1997). Here we employ a
well-characterized COS cell expression system to evaluate the contribution of the C-terminal
α-helices to the established biochemical properties of peripherin/rds. A series of C-terminal
deletion mutants were generated and shown to retain the capacity to interact with rom-1,
although none are able to promote membrane fusion. Collectively, these results suggest that
along with the fusion domain, other α-helical regions of the C-terminus contribute to the
membrane fusion process. We propose that progressive deletion of the C-terminus abrogates
the formation of a fusion competent peripherin/rds.

2. Materials and Methods
Author Manuscript

Generation of Peripherin/rds and Rom-1 Plasmid Constructs
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The open reading frames of peripherin/rds and rom-1 were isolated from bovine retinal
mRNA using RT–PCR (Ausubel, 1999). Peripherin/rds primers were designed using the
sequence provided by Connell and Molday (1990, Genbank accession J02884). To enable
protein detection, the upper 5′ primer was engineered with a 24-nucleotide sequence
corresponding to an 8 amino acid FLAG epitope tag (5′-ATGGACTAGAAGGACGACGACGACAAGGCGCTGCTCAAAGT-CAAATTT-3′)-The lower 3′ primer
corresponded to the following sequence: 5′-CTTCAGTGTGCAGAGGG-GACT-3′.
Similarly, rom-1 primers were designed using the sequence provided by Moritz and Molday
(1996, Genbank accession U72027). The upper 5′ primer was engineered with a 36nucleotide sequence corresponding to a 13 amino acid hemagglutinin (HA) epitope tag (5′ATGTGCTACCCTTACGACGTGCCTGACTACGCCAGCCTGGCGCCGGTGCTGCCCCTGGTC-3′)-The rom-1 lower 3′ primer
was 5′-CTAGGCCT-CAGGCAGACACTCCTTGG-3′. All reactions were carried out for 35
cycles using an annealing temperature of 63°C. The resulting PCR products were purified,
kinased and end-filled by standard procedures (Sambrook et al., 1989). The fragments were
then ligated to Sma I-digested pCI-Neo vector (Promega, Madison, WI, U.S.A.) and verified
by DNA sequencing.
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To generate the peripherin/rds deletion mutants, four additional lower 3′ primers were
designed. These primers correspond to progressive deletions of the C-terminus and are
presented below:

Deletion
number

3′ Lower PCR primer

Δ1

5′ - TCACAGCTTCTTCACACTCTCCAGAAA - 3′

Δ2

5′ - TCACTTCCAGGTCTCCGGCACGC - 3′

Δ3

5′ - TCAAAGCCAGCCCTCACTCTCGCAC - 3′

Δ4

5′ - TCAGTGCAGGTAGCGTAGCCCAA - 3′
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Each 3′ primer was used in conjunction with the FLAG-tagged peripherin/rds 5′ primer to
amplify the specific DNA fragments. All PCR reactions were performed for 35 cycles using
an annealing temperature of 60°C and peripherin/rds/pCI-Neo construct as template DNA.
Following PCR, the fragments were manipulated as described above and ligated to Sma Idigested pCI-Neo vector. All plasmid constructs were verified by sequence analysis and
purified by density gradient centrifugation (Sambrook et al., 1989).
Cell Culture and Transfections
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COS cells were grown in Dulbecco’s Modified Essential Media (DMEM) supplemented
with 10% fetal bovine serum. The cells were maintained in a humidified atmosphere of 5·5
% CO2 at 37°C and split 1 : 3 every third or fourth day. Transfections were performed using
Lipofectamine PLUS reagent (Invitrogen Life Technologies, Carlsbad, CA, U.S.A.) as
directed by the manufacturer. Cells were seeded 1 day prior to transfection as follows; 1 ×
105 cells per well in a six well plate, 1 × 106 cells/10 cm dish, or 3 × 106 cells/15 cm dish.
The amount of plasmid DNA was likewise based on culture vessel size; 1 µg per well, 4
µg/10 cm dish, or 12 µg/15 cm dish. All cells were harvested 48 hr post-transfection.
Immunolocalization and Immunoprecipitation Analysis
Immunolocalization studies were performed as described previously (Caradonna et al.,
1996). The M5 anti-FLAG monoclonal antibody (Sigma, St. Louis, MO, U.S.A.) was used
at a concentration of 10 µg ml−1 and the FITC-conjugated secondary antibody (Invitrogen
Life Technologies, Carlsbad, CA, U.S.A.) was used at a 1 : 1000 dilution. The slides were
viewed through a Ziess Axioscope fluorescence microscope equipped with an FITC-filter.
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For immunoprecipitation analysis, cell extracts were prepared in 1 ml of cold NP40 lysis
buffer (50 mM Tris–HCl, pH 7·5; 0·1% NP-40; 250 mM NaCl; 50 mM NaF; 5 mM EDTA). The
extracts were sonicated and then centrifuged at 13 000 g for 10 min at 4°C to remove
insoluble material. Protein concentrations were determined using the Bio-Rad protein assay
system as directed. Immunoprecipitation reactions (0·5 mg ml−1) were carried out as
described previously (Muller-Weeks et al., 1998) with one modification; all washes were
performed using NP40 lysis buffer. Again, the M5 anti-FLAG monoclonal antibody was
used at a concentration of 10 µg ml−1 and the anti-HA monoclonal antibody (Covance) was
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used at a 1 : 1000 dilution. Proteins recovered by immunoprecipitation were resolved by
10% SDS–PAGE and visualized by Western blotting.
Denaturing and Non-denaturing Gel Electrophoresis
SDS–PAGE was performed using the method of Laemmli (1970). Cell extracts were
denatured by adding an equal volume of 2 × SDS–PAGE sample buffer (100 mM Tris–HCl,
pH 6·8; 200 mM DTT; 4% SDS; 0·2 % bromophenol blue; 20 % glycerol) in the presence
(reducing) or absence (non-reducing) of 5 % beta-mercaptoethanol. The samples were
heated to 85°C for 10 min and loaded directly onto a 10% SDS–polyacrylamide gel. Nondenaturing tricine poly-acrylamide gel electrophoresis (10%) was performed by omitting
SDS from the system described by Schagger and von Jagow (1987). In this case, the samples
were prepared in the absence of BME and were not heated prior to loading. Gels were run at
30 mA for 2 hr.
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Western Blotting and Enzymatic Deglycosylation Studies
Western blotting was performed according to the procedure of Towbin et al. (1979).
Antibody binding and wash conditions were as previously described (Caradonna et al.,
1996). Protein bands were visualized using Sigma Fast BCIP/NBT (5-Bromo-4-Chloro-3Indolyl phosphate/ Nitro blue tetrazolium) substrate as directed.
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Deglycosylation of peripherin/rds was performed using endoglycosidase H (Endo H) as
outlined by New England Biolabs (Beverly, MA, U.S.A.). Initially, 2 µl of denaturing buffer
(50 mM sodium citrate, pH 5·5) were added to the extracts in a 15 µl reaction. The extracts
were denatured by heating to 100°C for 10 min. Subsequently, 1/10th volume of 10× G5
buffer (0·5 % SDS; 1 % β-mercaptoethanol) and 1 U of endoglycosidase H were added and
the reactions were incubated at 37°C overnight. Control extracts were also prepared as
described but lacked the enzyme.
Preparation and Labelling of ROS Membranes
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Retinal ROS membranes were isolated from 50 frozen, dark-adapted bovine retinas (J.A.
Lawson, Lincoln, NE, U.S.A.). Disk membranes and plasma membrane vesicles were
isolated using ricin-agarose and differential sucrose gradient centrifugation as described
(Boesze-Battaglia and Albert, 1989). The ROS plasma membranes were eluted from the
ricin-agarose pellet with 1 M galactose in 0·1 M sodium borate, pH 8·5. Both ROS plasma
membrane vesicle fractions and the isolated disk membranes were washed with 10 mM
Hepes, 1·0 mM EGTA. The plasma membrane vesicles were resuspended in 500 µl of 10 mM
Hepes, pH 7·4 and used within 24 hr of isolation. All manipulations were performed under
dim red light.
The phospholipid concentration of both ROS disk and plasma membrane samples was
determined as described by Bartlett (1959) and modified by Litman (1973). Disk membranes
were labelled with octade-cylrhodamine B chloride (R18, Molecular Probes, Junction City,
OR, U.S.A.) at a concentration of 1 mol% relative to total phospholipid. Plasma membrane
vesicles were similarly labelled with 5-(N-octadecanoyl) aminofluorescein (F18, Molecular
Probes, Junction City, OR, U.S.A.). Labelling was carried out in a minimum volume of
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ethanol for 30 min at room temperature as described (Boesze-Battaglia and Yeagle, 1992).
Labelled membranes were separated from unincorporated R18 or F18 by passing the samples
through a Sephadex G50 column and eluting with 100 mM NaCl, 10 mM glycine pH 7·5.
Preparation and Labelling of COS Intracellular Membranes
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COS cell intracellular membranes were isolated essentially as described by Oprian (1993).
Briefly, cell pellets were resuspended in 600 µl Tris–MgCl2 buffer (10 mM Tris–HCl pH 7·2,
2 mM MgCl2, and 10 mM glucose) and lysed by passage through a 26-gauge needle two
times. The resulting lysate was layered on a 3·8 ml cushion of 37% W/V sucrose in Tris–
MgCl2 buffer and centrifuged at 18 000 rpm for 20 min at 10°C (XL70 Ultra Centrifuge,
SW 60 rotor, Beckmann Instrument, Papo Gilo, CA, U.S.A.). The intracellular membranes
were collected in a 500 µl volume and an equal volume of Tris–MgCl2 buffer was added to
dilute the sucrose. Phosphate assays were performed to determine the total phospholipid
content of the intracellular membranes. The membranes were then labelled with F18 as
described above. A total volume of 3 ml of labelled membrane was collected from the
Sephadex G50 column.
Resonance Energy Transfer Fusion Assays
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The fusion between R18-labelled ROS plasma membrane vesicles and F18-labelled
membranes (ROS disk or intracellular COS) was measured using a well-characterized
resonance energy transfer (RET) assay (Struck et al., 1981; Partearroyo et al., 1994). The
fusion assays were performed at room temperature on a Perkin-Elmer LS 50B
spectrofluorometer (Gaithers-burg, MD, U.S.A.) equipped with a 96 well plate reader.
Fusion was initiated with addition of R18-labelled plasma membranes (final phospholipid
concentration = 0·20 nM) to F18-labelled membranes (final phospholipid concentration = 0·40
nM) already present in the well. Fluorescence intensity was measured at λex = 460 nm (F18
excitation) and at λem =524 nm (F18 emission) and λem = 592 nm (R18 emission) over a 2
min period. There was no additional change in R18 fluorescence for 30 min. The extent of
fusion (ΔR × 100) was calculated as a percent change in R18 intensity over time as described
previously (Partearroyo et al., 1994). The change in R18 intensity at a given time (ΔR) was
computed as follows:
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where I524 and I592 are the fluorescence intensities at 524 and 592 nm, respectively. The
subscripts T and I represent a given time point and the initial time point of each sample,
respectively. The extent of fusion (i.e., percent change in R18) was determined by
multiplying each ΔR value by 100 and this value was normalized to the calculated extent of
fusion observed between F18-labelled disks and R18-labelled plasma membrane. This latter
value was set as 100 % and all extents of fusion (ΔR × 100) were normalized to this
standard. The ΔR × 100 value obtained with mock-transfected cells was routinely subtracted
from ΔR × 100 of the samples. This value was variable, accounting for 25–40 % of ΔR
measured for peripherin/rds expressing cells. The final Ca2+ concentration in all assays was
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100 nM. Fusion could be inhibited with the addition of EDTA at a final concentration of 10
mM.
For specificity studies, F18-labelled COS intracellular membranes were preincubated with
PP-5 (72·5 nM) at 37°C for 20 min prior to the addition of R18-labelled ROS plasma
membrane. The sequence of the PP-5 peptide is H2N-V-P-E-T-W-K-A-F-L-E-S-V-K-K-LCOOH.

3. Results
Construction and Expression of Peripherin/rds Deletion Mutants
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The peripherin/rds C-terminus is a 64 amino acid extradiskal domain that spans amino acid
residues 282–345. This region is highly conserved (78% amino acid identity) between
human, bovine, canine, feline and rodent species suggesting a functional importance. ChouFasman and Robson-Garnier analyses of the peripherin/rds C-terminus predict three αhelical regions that are labelled 1, 2 and 3 in Fig. 1. To evaluate the functional significance
of these α-helical domains, a series of C-terminal truncation mutants were constructed. The
deletion endpoints were selected using the predicted secondary structural analysis (Fig. 1).
The Δ1 mutant, removes residues 326–345, corresponding to the third predicted α-helical
region. The Δ2 mutant, deletes residues 317–345, truncating the second α-helical region or
fusion peptide domain (Boesze-Battaglia et al., 1997, 1998). The Δ3 mutant removes
residues 307–345, thus eliminating the entire fusion domain. Finally, the Δ4 mutant
truncates the entire C-terminus (residues 288–345) encompassing all three α-helical regions.
Of note, both the Δ2 and Δ4 mutants approximate disease-linked mutations shown to cosegregate with retinal degenerative diseases (Felbor et al., 1997; Kohl et al., 1997).
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The full-length peripherin/rds and all mutants were engineered with an amino-terminal
FLAG-epitope tag to facilitate detection. Following transient transfections into COS cells,
protein expression was confirmed by immunohistochemical localization using monoclonal
antibody against the FLAG-tag (M5, Sigma, St. Louis, MO, U.S.A.) and FITC-conjugated
secondary antibody. The full-length, FLAG-tagged peripherin/rds is localized to the internal
membranes of COS cells (Fig. 2(A), panel 1). Importantly, control transfections using pCIneo vector alone are negative for specific peripherin/rds immunoreactivity (Fig. 2(A),
compare panels 1 and 2). These results are consistent with those previously reported by
Goldberg et al. (1995) for heterologously expressed peripherin/rds. Immuno-fluorescent
localization of mutants Δ2 and Δ4 shows that the staining pattern is unchanged, remaining
confined to the intracellular membranes (Fig. 2(A), panels 3 and 4). While it appears that the
Δ4 mutant may be expressed at higher levels (as compared with wild-type and Δ2), Western
blot analysis described below, demonstrates that it is not the case. Identical results were
obtained for mutants Δ1 and Δ3 (data not shown).
Peripherin/rds expression was also evaluated by Western blot analysis using equivalent
amounts of protein extract (25 µg) derived from each transfected sample. As shown in Fig.
2(B), the full-length peripherin/rds and deletion mutants are expressed to approximately
equal levels and can be readily detected using the FLAG-epitope tag. Full-length
peripherin/rds migrates as a 38 kDa protein. This is slightly larger than the native

Exp Eye Res. Author manuscript; available in PMC 2016 February 09.

Muller-Weeks et al.

Page 8

Author Manuscript

peripherin/rds purified from ROS owing to the presence of the 1 kDa FLAG-tag. Molecular
weights of the peripherin/rds mutants are reduced accordingly, ranging from 36 (Δ1) to 31·5
kDa (Δ4). It is also apparent that the peripherin/ rds proteins resolve as doublets or possibly,
as triplets. This is most likely due to the presence of both glycosylated and non-glycosylated
forms. Others have observed similar doublet patterns under both in vivo (Boesze-Battaglia et
al., 1997) and in vitro conditions (Wrigley et al., 2000). Collectively, these results suggest
that the epitope tag does not interfere with protein expression or localization. In addition,
progressive deletions of the C-terminus do not significantly alter protein expression levels or
cellular localization in the COS cell system.
Biochemical Characterization
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The consequences of these C-terminal mutations on several well-established biochemical
properties of peripherin/rds were then examined. These features include: (1) glycosylation,
(2) association with rom-1 and (3) the ability to form higher order complexes. Peripherin/rds
contains three possible N-linked glycosylation sites. In ROS, peripherin/rds is glycosylated
at a single site, asparagine 229, located within the D2 intradiskal loop (Kedzierski et al,
1999). Goldberg et al. (1995) have shown that heterologously expressed peripherin/rds is
incompletely glycosylated with both modified and unmodified forms present in extracts. To
examine the effects of the C-terminal deletions on glycosylation, extracts prepared from
transfected COS cells were treated with endoglycosidase H (Endo-H) as shown in Fig. 3. In
untreated extracts (− lanes), peripherin/rds migrates as doublets (full-length, Δ1 and Δ2) or
triplets (Δ3 and Δ4). Upon Endo-H treatment (+ lanes) however, all samples resolve as a
single, lower molecular weight band. An HA-tagged Rom-1 was also included in this
analysis and there was no apparent change in the presence or absence of Endo-H treatment
indicating that it is not glycosylated in this system (data not shown). The glycosylation
pattern associated with full-length peripherin/rds and mutants Δ1 and Δ2 is consistent with
previous results (Goldberg et al., 1995) and indicates that removing the terminal 29 amino
acids does not markedly interfere with glycosylation in this system. Interestingly, there is a
third, higher molecular weight band identifiable in mutants Δ3 and Δ4, which suggests the
use of alternate glycosylation sites.
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Peripherin/rds has been shown to complex non-covalently with a non-glycosylated homolog,
rom-1 (Bascom et al., 1992). The contribution of the peripherin/rds C-terminus to this
complex formation was determined by co-immunoprecipitation analysis using extracts from
cells co-transfected with each peripherin/rds construct (Δ1, Δ2, Δ3, and Δ4) and rom-1. For
detection purposes, rom-1 was engineered with a HA-tag and cloned into pCI-Neo. Extracts
prepared from COS cells co-transfected with the individual peripherin/rds constructs and
rom-1 were immunoprecipitated using anti-FLAG antibody (detects peripherin/rds). The
products were separated by 10 % SDS–PAGE and analysed by Western blotting with the
anti-HA antibody (detects rom-1). Fig. 4(A) shows that full-length peripherin/rds and each
of the mutants are able to co-precipitate the 39 kDa HA-tagged rom-1 protein. Control
reactions are presented in Fig. 4(B). Rom-1 is not detected in FLAG-immuno-precipitates
from mock-transfected cells or cells transfected with peripherin/rds or rom-1 individually
(Fig. 4(B), lanes 1–3). In a reciprocal experiment, all of the anti-HA immunoprecipitates
were shown to contain peripherin/rds (data not shown). Together these results show that
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removal of the peripherin/rds C-terminus does not eliminate its ability to interact with
rom-1.
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Native peripherin/rds also forms covalently linked homodimers, tetrameric and higher order
oligomeric complexes (Goldberg et al., 1995; Loewen and Molday, 2000). Of particular
significance are recent studies by Boesze-Battaglia et al. (2000) showing that a synthetic
peptide corresponding to the peripherin/rds fusion domain (PP-5) can assume a homotetrameric state mediated through non-covalent interactions between the α-helices. This
suggested that the C-terminus of peripherin/rds may participate in the formation of
homotetramers (oligomers) through non-covalent interaction. We assessed the ability of fulllength peripherin/rds and each deletion mutant to assume dimeric and oligomeric forms
using non-denaturing tricine gel electrophoresis. The proteins were visualized by Western
blotting with FLAG antibody and the results are presented in Fig. 5. Full-length peripherin/
rds, as well as peripherin/rds co-transfected with rom-1 predominantly form dimeric
(approximately 80 kDa) and higher order oligomeric (≥160 kDa) complexes. The same is
evident for mutants Δ1 and Δ2. Interestingly, while mutant Δ3 is likewise able to form
dimeric and higher order complexes, a significant monomeric band is also visible. The Δ4
mutant is present exclusively in monomeric and dimeric forms and is apparently unable to
efficiently form higher order complexes.
Analysis of Peripherin/rds Dependent Fusion
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Full-length bovine peripherin/rds has been shown to promote membrane fusion. The fusion
domain has been localized to residues 311–325 within the C-terminus of the protein. To
investigate how the predicted secondary structural domains within the C-terminus contribute
to membrane fusion, the peripherin/rds deletion mutants were studied for their ability to
promote membrane fusion. Using a RET method (Struck et al., 1981; Partearroyo et al.,
1994), the fusion between intracellular COS cell membranes containing the expressed
peripherin/rds proteins and bovine ROS plasma membrane vesicles was measured. In this
assay, each membrane species is labelled with a distinct fluorescent probe (F18 or R18 as
described in the ‘Materials and Methods’). As the membranes fuse, the lateral diffusion of
the fluorescent probes within the lipid bilayer allows them to come in close proximity. This
causes energy to be transferred from F18 (excited at 460 nm) to R18, thereby indirectly
exciting R18. As shown in Fig. 6(A), when R18-labelled ROS plasma membrane vesicles are
mixed with F18-labelled COS cell membranes isolated from cells expressing the full-length
peripherin/rds, an increase in R18 (solid line) and a decrease in F18 (dashed line)
fluorescence intensity is observed. Notably, the increase in fluorescence was specific for
only peripherin/rds containing COS cell membranes; when COS cells were transfected with
rom-1 alone, no fusion was detected (data not shown). The increase in R18 fluorescence
intensity was quantitated as described in the ‘Materials and Methods’ and normalized to
maximal fusion. Maximal fusion is designated as that between Relabelled plasma membrane
vesicles and F18-labelled disk membranes (containing native peripherin/rds) (Fig. 6(B), bar
1). Fusion mediated by COS cell membranes containing full-length peripherin/rds is
presented in Fig. 6(B), bar 2. All assays were performed using equivalent amounts of
phospholipid (0·40 nM) and peripherin/rds expression was verified by Western blot analysis
as shown in the inset. To confirm the specificity of the fusion as that due to peripherin/rds,

Exp Eye Res. Author manuscript; available in PMC 2016 February 09.

Muller-Weeks et al.

Page 10

Author Manuscript

the F18-labelled COS cell intracellular membranes were treated with PP-5, a synthetic
peptide, previously shown to inhibit disk-plasma membrane and peripherin/rds LUV-plasma
membrane fusion. The addition of PP-5 resulted in a decrease in the percent change in R18
fluorescence, suggesting inhibition of membrane fusion (Fig. 6(C)). Importantly, the
addition of bradykinin or PP-1 (a synthetic peptide to the N-terminal domain of
peripherin/rds (Boesze-Battaglia et al., 1997)) had no effect on fusion. The concentration of
PP-5 added is equal to the amount that inhibits fusion in model membrane studies.
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A comparison of the percent maximal fusion between ROS plasma membranes and COS cell
membranes expressing either the full-length or the four peripherin/rds deletion mutants can
be seen in Fig. 7. In contrast to the full-length peripherin/rds, very little to no fusion was
detectable with any of the four C-terminal deletion mutants. These values are in fact
equivalent or below those obtained with mock-transfected cells. Routinely, the fluorescence
observed with the mock-transfected samples corresponded to 2–3 % of maximal fusion and
importantly no increase in fluorescence intensity was observed over the time course of the
experiments with these cells. This inability to promote fusion is not due to the level of
protein expression, since all membranes contained similar levels of expressed protein as
shown in the inset of Fig. 7. Together these results suggest that none of deletion mutants
contained the minimal structural requirements necessary to promote fusion at a level
consistent with that of the full-length protein.

4. Discussion
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The results presented herein confirm and expand upon those reported by Goldberg et al.
(1995). As described previously, peripherin/rds expressed in COS cells localizes to
intracellular membranes, is glycosylated, forms heterotetramers with rom-1, and can form
homodimers and homotetramers (Goldberg et al., 1995; Loewen and Molday, 2000). Our
results extend these findings by showing that peripherin/rds expressed in COS cells can
function as a fusion protein by promoting fusion between COS cell membranes containing
peripherin/rds and vesicles prepared from ROS plasma membranes. The characteristics of
fusion between COS cell membranes and ROS plasma membrane vesicles are identical to
those observed with the native disk membranes and purified peripherin/rds. Specifically, it is
dependent upon nanomolar levels of calcium and can be inhibited by addition of PP-5, the
synthetic peptide mimicking the proposed fusion domain of peripherin/rds. Moreover, it is
specific for ROS plasma membrane as the target (data not shown), observations which
suggest that the fusion event is indeed dependent upon the presence of peripherin/rds in the
membranes and is not mediated by any of the other putative fusion proteins likely to also be
present in COS intracellular membranes.
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The present experiments were conducted to evaluate the role of the C-terminal a-helices of
peripherin/ rds. To facilitate protein detection, an N-terminal FLAG epitope tagged
peripherin/rds construct was generated for expression in COS cells. Importantly, our data
show that the presence of the N-terminal epitope tag does not alter the expression, or the
localization of peripherin/rds to intracellular membranes. As expected, the FLAG-tagged
peripherin/rds formed either homo-oligomers or hetero-oligomers with rom-1. The presence
of the N-terminal epitope tag also did not alter the fusogenic function of peripherin/ rds.
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Progressive deletion of the peripherin/rds C-terminus did not appear to alter significantly
protein expression or localization in the COS cell system. However, the utility of COS cells
is limited in that they are not polarized neuronal cells and certainly lack specific machinery
required for transport/sorting. Our results therefore, do not preclude the possibility that the
peripherin/rds C-terminus is important for directing localization of this protein in ROS. This
question is currently being addressed using peripherin/rds-GFP fusion constructs to create
transgenic Xenopus laevis (Lee et al., 2001; Tam et al., 2001). Initial results are conflicting
however, with one group reporting that the C-terminus is required for proper targeting to
ROS (Tam et al., 2001) and another reporting that the C-terminus is not required (Lee et al.,
2001).
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The C-terminal mutants also behave normally with respect to glycosylation and complex
formation with rom-1. Interestingly, when the entire C-terminal domain was removed in the
Δ4 mutant, additional slower migrating bands were seen (Fig. 3). It is possible that the Δ4
mutant is somewhat misfolded, thereby exposing a previously inaccessible glycosylation
site, which resulted in the additional bands. Alternatively, conformational changes resulting
from the loss of the entire C-terminus may have caused the changes in migration. In either
case, all protein forms were reduced to a single non-glycosylated form in the presence of
Endo-H. Native ROS peripherin/rds forms heterotetramers and higher order complexes with
rom-1 (Goldberg and Molday, 1996; Loewen and Molday, 2000). Loewen and Molday
(2000) have presented evidence suggesting that the sites of non-covalent interactions
between peripherin/rds and rom-1 are within the D2 loop of peripherin/rds. Our results
showing complex formation between rom-1 and each of the four mutated forms of
peripherin/rds suggest that the C-terminus is most likely not the site of interaction between
peripherin/rds and rom-1 and are consistent with previous results.
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Prior work has identified a region within the C-terminus of peripherin/rds proposed to be the
fusion domain of this protein (Boesze-Battaglia et al., 1997, 1998). This region
corresponding to amino acids 311–325 is an amphiphilic α-helix (Boesze-Battaglia et al.,
1998), a secondary structure common to other fusion proteins (White, 1990). Deletion
mutants within the C-terminus of peripherin/rds that either disrupt (Δ2 mutant) or omit (Δ3
and Δ4 mutants) this fusion domain, do not promote membrane fusion. These observations
provide strong support for our conclusions that the fusogenic region of peripherin/ rds
resides in the C-terminus and that the fusogenic domain within the C-terminus lies between
amino acids 311–325. In addition, the Δ2 mutant approximates the stop mutation that is
associated with a retinal degenerative disease state described by Felbor et al. (1997).
Similarly, Kohl et al. (1997) have described a retinal degenerative disease that is associated
with a second stop mutation in peripherin/rds corresponding to the Δ4 mutant. Our findings
represent the first biochemical abnormalities associated with these mutated forms of
peripherin/rds found in either degenerative disease.
Interestingly, the truncation mutant (Δ1) which lacks the last 20 amino acids of the Cterminus, but which retains an intact fusion domain (i.e., amino acids 311–325) did not
promote fusion. This observation was not altogether unexpected since the anti-peripherin/rds
monoclonal antibody 2B6, partially inhibits disk-plasma membrane and peripherin/rds
LUV-plasma membrane fusion. The epitope for this monoclonal antibody resides within the
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terminal 30 amino acids of the protein (Connell and Molday, 1990). Most likely, the 20
amino acid region missing in the Δ1 mutant is itself not a fusion domain because in vitro
studies using a synthetic peptide mimicking this region did not by itself promote fusion
between ROS plasma membrane vesicles and lipid vesicles (Boesze-Battaglia et al., 1997).
Of note, Stefano et al. (2002) have recently generated a peripherin/rds mutant lacking the Cterminal 10 amino acids and expressed this protein in MDCK cells. This mutation does not
disrupt the third α-helical domain and is capable of mediating membrane fusion. Similar
results were also seen in COS cells (Boesze-Battaglia, unpubl. res).
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Our previous studies have suggested that the fusion competent form of the fusion peptide
(a.k.a. PP-5) and by inference, peripherin/rds, requires the formation of a homotetrameric
complex. It is unlikely, however, that the failure of the Δ1 mutant to promote fusion can be
ascribed to an inability of this mutant to form tetramers because evidence of homo-oligomer
formation was detected with this mutant (Fig. 5). The finding that the Δ1 mutant forms
higher order complexes but is not fusion competent indicates that formation of a tetrameric
state is not solely responsible for conferring fusion competency. It can also be concluded
that domains within the C-terminus, other than the fusion domain (amino acids 311–322),
are required for the formation of a fusion competent form of peripherin/rds. Thus, the region
corresponding to the terminal 20 amino acids most likely aids in promoting the fusion
competency of this protein. Such domains have been described for viral membrane fusion
proteins and intracellular trafficking fusion proteins as contributing to the formation of
hairpins (a.k.a., SNAREpins), necessary to form a fusion pore (Weber et al., 1998). How
these regions interact and their structural identity remains to be determined.
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Fig. 1.

Schematic representation of the peripherin/rds C-terminus and deletion mutants. Amino acid
sequence of the peripherin/rds C-terminus is presented (residues 282–345). Chou-Fasman
and Robison-Garnier analyses of the region reveals three, α-helical regions that are denoted
by ▭ and numbered 1, 2 and 3. Helix 2 is the previously characterized fusion domain and the
corresponding amino acid sequence is underlined. This sequence also corresponds to the
peptide referred to as PP-5. Four C-terminal deletion mutants were constructed to disrupt the
α-helical structures and are denoted Δ1–Δ4. Deletion endpoints are marked with an arrow
and the length of each deletion is indicated on the right.
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Fig. 2.

Expression of the peripherin/rds constructs in COS cells. (A) Immunofluorescent
localization using M5 anti-FLAG primary antibody and FITC-labelled secondary antibody.
Cells were transiently transfected with the full-length peripherin/rds (panel 1), Δ2 (panel 3)
and Δ4 (panel 4) constructs. Panel 2 shows that no immunofluorescence is detected in
control cells transfected with pCI-Neo vector alone. (Note: The exposure time for panel 2
was increased in order to visualize cell structure since no specific fluorescence is
detectable.) (B) Western blot analysis of full-length peripherin/rds and each deletion mutant

Exp Eye Res. Author manuscript; available in PMC 2016 February 09.

Muller-Weeks et al.

Page 17

Author Manuscript

(Δ1–Δ4). Extracts (25 µg) from transiently transfected COS cells were fractionated by 10%
SDS–PAGE under reducing conditions. The proteins were analysed by Western blotting
using M5 anti-FLAG antibody. Molecular weight standards in kilodaltons are indicated on
the left.
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Fig. 3.

Enzymatic deglycosylation studies. Extracts (25 µg) prepared from transiently transfected
COS cells were treated with Endo H (+) or left untreated (−) as indicated. Proteins were
fractionated by 10% SDS–PAGE under reducing conditions and transferred to nitrocellulose
for Western blot analysis using the anti-FLAG M5 antibody. Each construct name is
indicated below the lanes.
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Fig. 4.
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Immunoprecipitation of peripherin/rds and rom-1 complexes. (A) Extracts (0·5 mg ml−1)
were prepared from COS cells transiently co-transfected with rom-1 plus the indicated
constructs and immunoprecipitated using the M5 anti-FLAG antibody (detects peripherin/
rds). The immunoprecipitates were fractionated by 10% SDS–PAGE and then analyzed by
Western blotting using the anti-HA monoclonal antibody (detects rom-1). Molecular weight
markers are indicated on the right and the location of antibody heavy and light chains are
indicated on the left. (B) Control reactions showing the absence of rom-1 staining in
immunoprecipitates from mock-transfected cells and cells transfected individually with
rom-1 and peripherin/rds. Immunoprecipitation reactions and Western blotting were
performed as described in (A), however, fractionation was by 12·6% SDS–PAGE. Lanes:
(1) mock-transfected COS cells; (2) cells transfected with HA-rom-1; (3) cells transfected
with FLAG-peripherin/rds; (4) cells co-transfected with HA-rom-1 and FLAG-peripherin/
rds.
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Fig. 5.

Non-denaturing electrophoresis of full-length peripherin/rds and the deletion mutants.
Extracts (30 µg) from cells transiently transfected with the indicated constructs were
fractionated by 10 % non-denaturing tricine gel electrophoresis. The proteins were
transferred to nitrocellulose for Western blotting using anti-FLAG M5 monoclonal antibody.
Monomeric, dimeric and higher order complex protein forms are indicated by brackets on
the left. Molecular weight markers in kilodaltons are indicated on the right.
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Fig. 6.

Resonance energy transfer from F18 to R18. (A) Presented above is a representative scan of
the increase in R18 fluorescence emission at 592 nm (solid line) and the concomitant
decrease in F18 fluorescence emission at 524 nm (dashed line) when F18-labelled COS cell
membranes containing peripherin/rds fuse with Relabelled ROS plasma membrane. The
excitation wavelength is 460 nm. (B) Maximal fusion between Relabelled ROS plasma
membrane and F18-labelled COS cell membranes containing peripherin/rds or F18-labelled
disk membranes. The RET assay was performed as described in the ‘Materials and Methods’
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and maximal percent fusion was calculated. Western blot analysis was also performed to
confirm peripherin/rds expression in both samples (shown in inset). Inset, lane 1 disk
membrane peripherin/rds; Western blot probed with monoclonal antibody 2B6 and lane 2,
FLAG-tagged peripherin/rds in COS cell membranes; Western probed with anti-FLAG
antibody. (C) The percent change in R18 fluorescence over time (in sec) upon energy
transfer when Relabelled ROS plasma membranes are mixed with F18-labelled COS cell
membranes, in the presence [—◆—] and absence [—■—] of PP-5.
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Fig. 7.
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RET fusion assay between R18-labelled plasma membrane vesicles and various target
membranes. The percent maximal fusion is shown for mixtures of Relabelled plasma
membrane vesicles and F18-labelled, disks (bar 1), or COS cell membranes from cells
transfected with full-length FLAG-peripherin/rds (bar 2), Δ1 mutant (bar 3), Δ2 mutant (bar
4), Δ3 mutant (bar 5) or Δ4 mutant (bar 6). Inset, Western blot probed with anti-FLAG
antibody showing the amount of expressed protein in each sample.
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